查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863376

影像CRO市場：按提供者類型、服務類型、影像模式、臨床試驗階段、適應症和最終用戶分類－2025-2032年全球預測

Imaging CRO Market by Provider Types, Service Type, Imaging Modality, Phase of Clinical Trials, Indication, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，成像 CRO 市場將成長至 33.8 億美元，複合年成長率為 6.17%。

關鍵市場統計數據
基準年 2024 20.9億美元
預計年份：2025年 22.1億美元
預測年份 2032 33.8億美元
複合年成長率 (%) 6.17%

建構現代化的影像臨床研究生態系統，使營運能力與科學和監管要求一致，從而確保試驗成功。

診斷影像臨床研究領域需要嚴格且獨立地整合營運能力、科學標準和監管準備，以支援生命科學和醫療設備企業的決策者。本執行摘要介紹了影響外包診斷影像服務的核心主題，重點闡述了卓越營運、專業技術以及整合資料管理如何共同影響研究設計和執行。以下分析提取了關鍵產業趨勢、細分資訊、區域差異以及建議的策略行動，供經營團隊參考，以最佳化供應商選擇、資源分配和研究監管。

本報告始終強調實際應用價值而非抽象趨勢，確保研究結果能應用於實際專案規劃。引言部分闡述了關鍵促進因素——包括不斷推進的定量影像終點、對互操作系統的需求以及不斷變化的監管要求——這些因素共同促使我們採取更具戰略性的方式與影像CRO合作。最終，讀者將獲得一個平衡的觀點，該視角將技術進步與營運限制相結合，為後續章節奠定了基礎。後續章節將深入探討轉型變革、關稅影響、市場區隔、區域性考量以及公司層面的行動。透過預先設定這些背景訊息，本摘要有助於讀者理解，並能快速將研究結果轉化為採購、研究設計和夥伴關係決策。

影像技術、資料整合和監管要求的進步如何融合，從而重新定義供應商的能力和試驗運作？

診斷影像臨床研究領域正經歷變革性的轉變，這主要得益於影像技術的進步、資料實踐的改進以及監管力度的加強，這些因素共同重塑了醫療服務提供者的角色和服務模式。供應商正從單一模態服務轉向整合影像擷取監管、集中閱片和縱向資料協調的平台，以支援複雜的終點指標和分散的研究要素。同時，定量影像生物標記的日益普及推動了對標準化採集通訊協定、跨供應商校準方法以及與供應商無關的分析工具鏈的投資。

這些變化要求企劃團隊加強臨床運作、影像核心實驗室和生物統計部門之間的協作，以確保影像衍生終點的穩健性和可重複性。此外，業界正日益轉向雲端基礎的影像管理和安全的聯邦學習方法，以在保護資料隱私的同時實現多中心模型開發。同時，關於演算法解讀和數位生物標記檢驗的監管對話也在不斷發展，這使得透明的檢驗流程和審核的資料管理變得愈發重要。這些協同效應正迫使醫療服務提供者提升其在資料整合、品質保證和監管支援方面的能力，並促使申辦方優先選擇能夠展現系統嚴謹性和適應性服務模式的供應商。

2025年新關稅措施的營運影響：診斷影像服務的採購本地化、成本分配策略和合約風險緩解

2025年實施的新關稅的累積影響進一步增加了依賴跨境設備採購和跨國供應鏈的診斷影像服務供應商的營運複雜性。關稅導致診斷影像硬體、專用耗材和某些輔助技術的到岸成本增加，迫使服務提供者重新評估其籌資策略、最佳化庫存計劃，並重新考慮專科中心模式和分散式服務交付的經濟效益。

因此，影像設備供應商正在協商長期供應協議，以加速關鍵供應鏈的本地化，並穩定價格和服務連續性。這項轉變進一步強化了利用遠端影像閱片和集中處理來減少研究中心之間重複部署本地設備的必要性。此外，申辦方和供應商在選擇影像設備以及在通訊協定中明確掃描儀要求時，越來越重視研究開展的總落地成本，並優先考慮能夠降低跨境旅行及相關海關手續複雜性的解決方案。

同時，不斷變化的關稅環境促使合約條款中關於成本轉嫁、風險分配以及應對未來貿易政策變化的緊急時應對計畫被正式寫入合約。作為一項臨時措施，一些服務供應商已開始提供區域服務包和區域倉儲服務，以在維持服務水準的同時，吸收部分採購成本的波動。這些調整表明，貿易政策趨勢正在轉化為以影像為重點的臨床調查計畫在供應商選擇、營運規劃和合約管治方面的實際變化。

一種多維細分框架，揭示了提供者類型、服務線、模式、試驗階段、適應症和最終用戶如何影響診斷影像檢查決策。

了解市場細分，例如供應商類型、服務線、影像模式、臨床試驗階段、適應症和最終用戶，對於就供應商選擇和專案設計做出明智的決策至關重要。在供應商類型方面，全方位服務的合約研究組織 (CRO)、專業影像核心實驗室和專注於影像的 CRO 之間的區別，決定了申辦方獲得的是端到端的管理解決方案，還是集中閱片和影像管治方面的特定功能。在服務類型方面，臨床影像服務、資料管理和整合、計劃管理和試驗支援以及法規和合規服務之間的區別，決定了影像活動是融入到更廣泛的試驗營運中，還是作為一項獨立的技術服務進行外包。

此外，影像方式（CT、MRI、PET 和超音波）和亞專科（例如多切面CT 與螺旋 CT、彌散張量磁振造影與功能性磁振造影、3D/4D超音波與多普勒超音波）的差異，對研究中心的選擇標準、閱片者的專業水平和採集通訊協定的設計均有顯著影響。根據臨床試驗階段，I 期、II 期和 III 期研究需要不同的終點檢驗、影像審查頻率以及所需的監管文件範圍。根據適應症，臨床重點關注心臟病學、感染疾病、肌肉骨骼系統疾病、神經病學、腫瘤學和眼科學，這些因素決定了成像方式的選擇和閱片者的專業水平，以匹配疾病特異性的影像生物標記。最後，在基於最終用戶的分類中，生物技術公司、醫療設備製造商、製藥公司以及科研和學術機構的需求會影響採購行為、首選合約模式以及對科研合作的期望。總的來說，這些分類觀點提供了一個多維框架，以支援有針對性的供應商評估、營運設計選擇和資源分配決策。

區域營運實務和適應策略（美洲、歐洲、中東和非洲、亞太地區）會影響診斷影像研究的效能和資料品質。

區域趨勢對影像臨床研究服務的提供、合約簽訂和監管方式有顯著影響。認知到這些差異對於全球專案規劃至關重要。在美洲，主要學術研究機構的集中以及成熟的專業影像供應商網路，使得開展需要嚴格影像標準和可擴展的集中閱片流程的複雜大規模試驗成為可能。該地區的轉型因素包括對互通性的重視，以及支付方和監管機構就影像衍生替代終點展開的積極討論，這些都將影響通訊協定設計和證據生成策略。

在歐洲、中東和非洲地區，報銷架構、監管協調工作以及臨床基礎設施的差異，造就了更多元化的服務環境。在該地區開展業務的申辦方必須制定差異化的研究中心選擇策略，並做好準備，以適應各種掃描器型號、語言要求和當地資料保護制度。同時，亞太地區正處於快速發展階段，對影像硬體和學術臨床研究能力的投資正在加速成長，但區域物流、研究者培訓和影像校準物流等營運挑戰仍然是關注的焦點。過渡性方法，例如區域影像處理中心、本地化培訓計畫和適應性契約，有助於彌合能力差距，並在跨司法管轄區的研究中保持數據品質的一致性。這種地理觀點對於設計符合全球計畫目標、切合當地實際情況的影像策略至關重要。

供應商策略、技術投資和夥伴關係模式如何塑造診斷影像服務的競爭差異化和贊助商參與度

一些成熟的醫療機構和眾多專業實驗室正攜手合作，共同塑造診斷影像服務的競爭格局。他們的行動中湧現出幾個通用的主題，這些主題對申辦者的參與度產生了影響。大型醫療機構透過投資可擴展的影像管理平台、檢驗的讀片演算法和整合的品管系統來脫穎而出，從而確保各站點效能的一致性。同時，專注於特定領域的診斷影像核心實驗室則憑藉其在影像模式和治療領域的專業知識深度展開競爭，提供高度客製化的通訊協定開發和讀片培訓，以應對複雜的終點指標。

除了這些企業級策略之外，企業越來越重視透過夥伴關係和聯盟來拓展技術能力，例如人工智慧驅動的影像判讀、雲端原生資料整合以及用於多中心研究的聯合分析。此外，企業正在將監管諮詢和證據產生規劃納入其服務組合，從而減少申辦者工作流程中的摩擦。在營運方面，那些強調透明檢驗流程、完善審核追蹤和客戶可存取儀錶板的企業，越來越受到既追求科學嚴謹性又注重營運透明度的申辦方的青睞。最後，靈活的合約模式和提供本地支援的能力也是重要的競爭優勢，有助於確保跨國試驗能夠採用一致的影像標準和可預測的時間表。

經營團隊可採取實際行動，協調供應商能力、資料管治和合約簽訂方式，以確保強大的成像終端和營運彈性。

產業領導者應採取一系列切實可行的措施，以維持專案發展勢頭，管控營運風險，並從影像衍生終點創造科學價值。首先，供應商選擇標準應與已證實的特定成像方式專業知識和標準化的採集通訊協定相匹配，以確保不同站點和閱片者之間的一致性。其次，要求演算法或半自動閱片工具提供透明的檢驗文檔，並遵守審核的資料管理流程，以促進與監管機構的溝通。第三，籌資策略應考慮與供應鏈風險和關稅相關的成本波動，優先選擇具有成熟在地採購或區域倉儲能力的供應商。

此外，申辦方應在通訊協定設計初期就引入跨職能管治，讓影像專家、生物統計學家和臨床運作負責人參與其中，以避免返工和終點定義模糊。他們還應優先選擇能夠提供整合資料管理功能和互通性的供應商，以減少人工核對並加快資料鎖定。最後，他們應考慮平衡風險和靈活性的合約結構，例如與交付成果掛鉤的里程碑付款，並協商明確的服務等級協定 (SLA) 和緊急時應對計畫。全面實施這些措施將有助於提高試驗執行的穩健性，增強對影像終點的信心，並促進與監管機構的順暢溝通。

本報告的證據基礎是透過混合方法建構的，該方法整合了專家訪談、通訊協定標準和同行評審文獻，以檢驗操作知識和調查方法的嚴謹性。

本報告的研究途徑結合了與主題專家的結構化面對面對話、與行業相關人員的結構化定性訪談，以及對已發布的監管指南和同行評審文獻的嚴謹二手資料研究，以確保評估的平衡性和檢驗。主要研究包括與影像科學家、臨床營運總監和監管事務專家進行諮詢，檢驗營運場景並識別研究執行中出現的新挑戰。這些訪談為貫穿本報告的分析框架的建構提供了訊息，尤其是在模態選擇、閱片者檢驗和資料整合模式方面。

二次研究回顧了目前關於技術標準、成像通訊協定指南和定量成像生物標記的文獻，以闡明操作最佳實踐和監管要求。數據綜合強調多資訊來源三角驗證，以提高可靠性並盡可能達成共識。在整個調查方法中，我們始終專注於記錄假設、保持對關鍵資訊來源的可追溯性，並保護關鍵資訊提供者的隱私。這種混合方法為本報告中提出的策略指導和建議提供了切實可行的實證基礎。

將營運重點、監管準備和策略供應商選擇連結的整體觀點，可確保影像技術為臨床專案目標的實現做出貢獻。

本執行摘要了依賴外包診斷影像服務的團隊在決策過程中需要考慮的關鍵營運、監管和商業因素。它重點闡述了影像模式的專業化、資料整合能力以及不斷變化的監管預期如何改變供應商的選擇標準和研究設計方法。分析表明，需要儘早影像終點、標準化採集通訊協定以及針對人工和演算法輔助解讀的可靠檢驗流程達成跨職能共識。

此外，摘要強調了供應鏈和關稅壓力對採購和合約簽訂的實際影響，並提案申辦方積極將風險緩解措施納入其供應商策略。應對區域差異需要針對站點選擇和數據協調制定客製化方法。同時，企業層面的趨勢表明，與兼具專業知識和透明、擴充性平台的供應商合作具有重要價值。總之，強烈建議申辦方將這些發現轉化為採購流程、通訊協定製定和管治的具體改進，以確保診斷影像能為證據產生和臨床專案的整體成功做出貢獻。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴展用於分散式測試工作流程的AI驅動影像分析平台
  • 將先進的數位病理成像服務整合到多機構腫瘤研究中
  • 標準化定量成像生物標記以支持全球監管申報
  • 引入雲端基礎的影像管理系統，實現多個設施之間的即時協作
  • 自動病灶檢測演算法的出現提高了縱向研究的準確性
  • 更多地使用遠端影像判讀服務來縮短審理週期並提高效率
  • 利用多模態影像終點進行免疫腫瘤學試驗的全面評估
  • 引入基於人工智慧的品管檢查，以減少人工影像判讀錯誤。
  • 擴展整合成像和數位生物標記解決方案以實現患者分層客製化
  • 擴展功能性磁振造影終點，用於在後期臨床試驗中監測神經退化性疾病

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按提供者類型分類的影像CRO市場

  • 全方位CRO服務
  • 影像核心實驗室
  • 成像 CRO

9. 按服務類型分類的成像 CRO 市場

  • 臨床影像服務
  • 資料管理與整合
  • 計劃管理和測試支持
  • 法規與合規

第10章：以成像方式分類的成像CRO市場

  • 電腦斷層掃描（CT）
    • 多切面CT
    • 螺旋CT
  • 磁振造影（MRI）
    • 擴散張量造影
    • 功能性磁振造影
  • 正子斷層掃描（PET）
  • 超音波
    • 3D和4D超音波
    • 多普勒超音波

第11章 依臨床試驗階段分類的影像CRO市場

  • 第一階段
  • 第二階段
  • 第三階段

第12章：按適應症分類的影像CRO市場

  • 心臟病學
  • 感染疾病
  • 肌肉骨骼系統
  • 神經病學
  • 腫瘤學
  • 眼科

第13章：依最終用戶分類的成像CRO市場

  • 生技公司
  • 醫療設備製造商
  • 製藥公司
  • 研究和學術機構

第14章：按地區分類的成像CRO市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 影像CRO市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國影像CRO市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH
    • Biospective Inc.
    • Biotrial
    • Bruker Corporation
    • Celentyx Ltd.
    • Charles River Laboratories, Inc.
    • Clario
    • EPS Corporation
    • GVK Biosciences Private Limited
    • ICON PLC
    • Image Analysis Group
    • Intelerad Medical Systems Incorporated
    • IQVIA Inc.
    • Median Technologies PLC
    • Medidata by Dassault Systemes SE
    • MERIT CRO, Inc.
    • Micron, Inc.
    • Mint Medical Inc.
    • MUSASHI IMAGE JOHO CO.,LTD.
    • Parexel International Corporation
    • Perceptive Informatics LLC
    • Visikol, Inc.
    • WCG Clinical, Inc.
Product Code: MRR-2E76C3E47FC3

The Imaging CRO Market is projected to grow by USD 3.38 billion at a CAGR of 6.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.09 billion
Estimated Year [2025] USD 2.21 billion
Forecast Year [2032] USD 3.38 billion
CAGR (%) 6.17%

Framing the contemporary imaging clinical research ecosystem to align operational capabilities with scientific and regulatory demands for trial success

The imaging clinical research landscape demands a rigorous, independent synthesis of operational capabilities, scientific standards, and regulatory alignment to support decision-makers across life sciences and medical device organizations. This executive summary introduces the core themes that shape outsourced imaging services, highlighting how operational excellence, modality specialization, and integrated data management converge to influence trial design and execution. The following analysis distills critical industry movements, segmentation intelligence, regional nuances, and recommended strategic responses that executives can use to refine vendor selection, resource allocation, and trial oversight.

Throughout the report, emphasis is placed on practical implications rather than abstract trends, ensuring that insights can be applied to real-world program planning. The introduction frames key drivers such as rising sophistication in quantitative imaging endpoints, the need for interoperable data systems, and evolving regulatory expectations that together demand a more strategic approach to imaging CRO engagement. Consequently, readers will find a balanced view that connects technological advances with operational constraints, offering a foundation for subsequent sections that detail transformative shifts, tariff impacts, segmentation implications, regional considerations, and company-level behavior. By setting this context up front, the summary aims to accelerate comprehension and support rapid translation of intelligence into procurement, trial design, and partnership decisions.

How converging advances in imaging modalities, data integration, and regulatory expectations are redefining vendor capabilities and trial operations

The imaging clinical research field is experiencing transformative shifts driven by advances in imaging technologies, data practices, and regulatory scrutiny that together are reshaping provider roles and service delivery models. Vendors are moving beyond single-modality service delivery toward integrated platforms that combine image acquisition oversight, centralized reading, and longitudinal data harmonization to support complex endpoints and decentralized trial elements. At the same time, the growing adoption of quantitative imaging biomarkers is prompting investments in standardized acquisition protocols, cross-vendor calibration approaches, and vendor-agnostic analytic toolchains.

As a result of these changes, project teams must now emphasize tighter collaboration between clinical operations, imaging core labs, and biostatistics to ensure image-derived endpoints are robust and reproducible. Furthermore, the industry is seeing enhanced focus on cloud-based image management and secure federated learning approaches to preserve data privacy while enabling multi-site model development. In addition, regulatory dialogues are evolving to address validation of algorithmic reads and digital biomarkers, which increases the importance of transparent validation pathways and audit-ready data curation. These converging forces are encouraging providers to expand capabilities in data integration, quality assurance, and regulatory support, and they are influencing sponsors to prioritize vendors who can demonstrate systemic rigor and adaptive service models.

Operational implications of new 2025 tariff measures driving procurement localization, cost allocation strategies, and contractual risk mitigation in imaging services

The cumulative effect of new tariff measures implemented in 2025 has introduced additional operational complexity for imaging service providers that rely on cross-border equipment procurement and multinational supply chains. Tariff-driven increases in the landed cost of imaging hardware, specialized consumables, and certain ancillary technologies have compelled providers to re-evaluate procurement strategies, optimize inventory planning, and reconsider the economics of center-of-excellence models versus distributed service delivery.

Consequently, imaging providers have accelerated efforts to localize critical supply chains and to negotiate long-term supplier agreements that can stabilize pricing and service continuity. This shift has also intensified the rationale for leveraging remote image reading and centralized processing to mitigate the need for repeated on-site equipment deployments across trial sites. Moreover, sponsors and providers are increasingly assessing the total landed cost of trial execution when selecting imaging modalities or specifying scanner requirements in protocols, prioritizing solutions that reduce cross-border movements and associated customs complexity.

In parallel, the tariff environment has prompted more structured contract language around cost pass-through, risk allocation, and contingency planning to manage potential future trade policy fluctuations. As a transitional measure, some service providers are offering localized service bundles and regional warehouses to maintain service level commitments while absorbing some procurement cost volatility. Together, these adaptations illustrate how trade policy dynamics translate into pragmatic changes in vendor selection, operational planning, and contractual governance across imaging-focused clinical research programs.

A multidimensional segmentation framework revealing how provider types, service lines, modalities, trial phases, indications, and end users shape imaging research decisions

Understanding how the market segments across provider types, service lines, imaging modalities, clinical trial phases, indications, and end users is essential to making informed decisions about vendor selection and program design. Based on provider types, distinctions between full-service contract research organizations, specialized imaging core labs, and imaging-focused CROs determine whether a sponsor will receive an end-to-end managed solution or a targeted competency in centralized reads and imaging governance. Based on service type, differences among clinical imaging services, data management and integration, project management and trial support, and regulatory and compliance offerings shape the extent to which imaging is embedded within broader trial operations or contracted as a discrete technical service.

Further, based on imaging modality, variation across CT, MRI, PET, and ultrasound-and the sub-specializations such as multislice versus spiral CT, diffusion tensor and functional MRI, and 3D/4D versus Doppler ultrasound-creates important implications for site qualification, reader expertise, and acquisition protocol design. Based on phase of clinical trials, requirements in Phase I, Phase II, and Phase III studies differ in terms of endpoint validation, frequency of imaging assessments, and the degree of regulatory documentation required. Based on indication, the clinical focus on cardiology, infectious diseases, musculoskeletal, neurology, oncology, and ophthalmology drives modality selection and reader specialization to align with disease-specific imaging biomarkers. Finally, based on end-user, the needs of biotechnology firms, medical device companies, pharmaceutical companies, and research and academic institutions influence procurement behavior, desired contracting models, and expectations for scientific collaboration. When taken together, these segmentation lenses provide a multidimensional framework that supports targeted vendor evaluation, operational design choices, and resource allocation decisions.

Regional operational realities and adaptive strategies across the Americas, EMEA, and Asia-Pacific that influence imaging trial execution and data quality

Regional dynamics exert a material influence on how imaging clinical research services are delivered, contracted, and regulated, and acknowledging these differences is vital for global program planning. In the Americas, concentrations of leading academic centers and a well-established network of specialized imaging vendors facilitate complex, high-volume trials that demand rigorous imaging standards and scalable centralized reading operations. Transitional factors in the region include an emphasis on interoperability and an active payer and regulatory discourse around imaging-derived surrogate endpoints, which affects protocol design and evidence generation strategies.

Across Europe, the Middle East, and Africa, variability in reimbursement frameworks, regulatory harmonization efforts, and clinical infrastructure leads to a more heterogeneous service landscape. Sponsors operating in this region must plan for differentiated site qualification strategies and be prepared to manage varied scanner models, language requirements, and local data protection regimes. Meanwhile, Asia-Pacific presents a rapidly evolving environment in which investments in imaging hardware and academic clinical research capacity are accelerating, yet operational considerations such as regional standardization, investigator training, and logistics for imaging calibration remain focal points. In each region, transitional approaches-such as regional hubs for image processing, localized training programs, and adaptive contracting-help bridge capability gaps and support consistent data quality across multi-jurisdictional studies. This geographical perspective is essential for designing pragmatic, regionally sensitive imaging strategies that align with global program objectives.

How provider strategies, technology investments, and partnership models are shaping competitive differentiation and sponsor engagement in imaging services

A small number of well-established providers and a broader set of specialized labs collectively define the competitive landscape for imaging services, and company behaviors reveal several consistent themes that affect sponsor engagement. Leading providers are differentiating through investments in scalable image management platforms, validated reading algorithms, and integrated quality management systems that enable consistent cross-site performance. At the same time, niche imaging core labs are competing on depth of modality expertise and therapeutic area specialization, offering highly tailored protocol development and reader training that address complex endpoints.

These company-level strategies are accompanied by an increasing focus on partnerships and alliances that extend technical capabilities into areas such as AI-augmented reads, cloud-native data integration, and federated analytics for multi-site studies. Additionally, firms are broadening service portfolios to include regulatory consulting and evidence generation planning to reduce friction in sponsor workflows. Operationally, companies that emphasize transparent validation processes, robust audit trails, and client-accessible dashboards tend to gain preference among sponsors seeking both scientific rigor and operational transparency. Finally, competitive differentiation is also driven by the ability to deliver flexible contracting models and localized support, which helps enable multinational trials with consistent imaging standards and predictable timelines.

Practical actions for executives to align vendor capabilities, data governance, and contracting approaches to secure robust imaging endpoints and operational resilience

Industry leaders should adopt a set of pragmatic actions to maintain program momentum, manage operational risk, and capture scientific value from imaging-derived endpoints. First, align vendor selection criteria with specific modality expertise and evidence of standardized acquisition protocols to ensure consistency across sites and readers. Second, require transparent validation documentation for any algorithmic or semi-automated reading tools and insist on audit-ready data curation processes that facilitate regulatory interactions. Third, incorporate procurement strategies that account for supply chain risks and tariff-related cost variability by favoring vendors with demonstrable localized sourcing or regional warehousing capabilities.

Additionally, sponsors should embed cross-functional governance that brings imaging specialists, biostatisticians, and clinical operations into early protocol design to avoid rework and endpoint ambiguity. It is also advisable to prioritize providers that offer integrated data management and interoperability features to reduce manual reconciliation and accelerate data lock. Finally, consider contracting modalities that balance risk and flexibility, such as milestone-based payments tied to deliverables, while negotiating clear service-level agreements and contingency plans. Taken together, these actions will support more resilient trial execution, higher confidence in imaging endpoints, and smoother regulatory dialogues.

A mixed-methods evidence base integrating expert interviews, protocol standards, and peer-reviewed literature to validate operational insights and methodological rigor

The research approach underpinning this report combines systematic primary engagement with subject-matter experts, structured qualitative interviews with industry stakeholders, and rigorous secondary analysis of publicly available regulatory guidance and peer-reviewed literature to ensure a balanced and verifiable assessment. Primary engagements included consultations with imaging scientists, clinical operations leads, and regulatory affairs specialists to validate operational scenarios and identify emerging pain points in trial execution. These interviews informed the development of analytic frameworks used throughout the report, particularly with respect to modality selection, reader validation, and data integration patterns.

Secondary research encompassed a review of technical standards, imaging protocol guidelines, and recent publications on quantitative imaging biomarkers to contextualize operational best practices and regulatory expectations. Data synthesis emphasized triangulation across sources to enhance reliability and to surface consensus where possible. Throughout the methodology, careful attention was paid to documenting assumptions, maintaining traceability of insights to source inputs, and preserving confidentiality of primary contributors. Together, this mixed-methods approach yields a pragmatic, evidence-based foundation for the strategic guidance and recommendations offered in the report.

Summative perspective linking operational priorities, regulatory readiness, and strategic vendor choices to ensure imaging contributes reliably to clinical program objectives

This executive summary synthesizes key operational, regulatory, and commercial considerations that will inform decision-making for teams that rely on outsourced imaging services. It highlights how modality specialization, data integration capabilities, and evolving regulatory expectations are changing provider selection criteria and trial planning practices. The analysis reinforces the need for early, cross-functional alignment on imaging endpoints, standardized acquisition protocols, and robust validation pathways for both human reads and algorithm-assisted interpretations.

Moreover, the summary underscores the practical implications of supply chain and tariff pressures on procurement and contracting, suggesting that sponsors proactively integrate risk mitigation measures into their vendor strategies. Regional differences require tailored approaches to site qualification and data harmonization, while company-level behaviors point to the value of partnering with providers who combine domain expertise with transparent, scalable platforms. In closing, the conclusion urges sponsors to translate the insights into concrete changes in procurement, protocol development, and governance so that imaging contributes reliably to evidence generation and to the overall success of clinical programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of AI-driven imaging analysis platforms for decentralized trial workflows
  • 5.2. Integration of advanced digital pathology imaging services into multi center oncology studies
  • 5.3. Standardization of quantitative imaging biomarkers to support regulatory submissions globally
  • 5.4. Adoption of cloud based image management systems for real time collaboration across sites
  • 5.5. Emergence of automated lesion detection algorithms for enhanced accuracy in longitudinal studies
  • 5.6. Rising utilization of remote image reading services to accelerate trial timelines and efficiency
  • 5.7. Leveraging multi modal imaging endpoints for comprehensive assessment in immuno oncology trials
  • 5.8. Implementation of AI based quality control checks to reduce manual image interpretation errors
  • 5.9. Growth of integrated imaging and digital biomarker solutions for personalized patient stratification
  • 5.10. Expansion of functional MRI endpoints for neurodegenerative disease monitoring in late stage trials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Imaging CRO Market, by Provider Types

  • 8.1. Full-Service CROs
  • 8.2. Imaging Core Labs
  • 8.3. Imaging CROs

9. Imaging CRO Market, by Service Type

  • 9.1. Clinical Imaging Services
  • 9.2. Data Management & Integration
  • 9.3. Project Management & Trial Support
  • 9.4. Regulatory & Compliance

10. Imaging CRO Market, by Imaging Modality

  • 10.1. Computer Tomography (CT) Scan
    • 10.1.1. Multislice CT
    • 10.1.2. Spiral CT
  • 10.2. Magnetic Resonance Imaging (MRI)
    • 10.2.1. Diffusion Tensor Imaging
    • 10.2.2. Functional MRI
  • 10.3. Positron Emission Tomography (PET)
  • 10.4. Ultrasound
    • 10.4.1. 3D & 4D Ultrasound
    • 10.4.2. Doppler Ultrasound

11. Imaging CRO Market, by Phase of Clinical Trials

  • 11.1. Phase I
  • 11.2. Phase II
  • 11.3. Phase III

12. Imaging CRO Market, by Indication

  • 12.1. Cardiology
  • 12.2. Infectious Diseases
  • 12.3. Musculoskeletal
  • 12.4. Neurology
  • 12.5. Oncology
  • 12.6. Ophthalmology

13. Imaging CRO Market, by End-User

  • 13.1. Biotechnology Firms
  • 13.2. Medical Device Companies
  • 13.3. Pharmaceutical Companies
  • 13.4. Research & Academic Institutions

14. Imaging CRO Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Imaging CRO Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Imaging CRO Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH
    • 17.3.2. Biospective Inc.
    • 17.3.3. Biotrial
    • 17.3.4. Bruker Corporation
    • 17.3.5. Celentyx Ltd.
    • 17.3.6. Charles River Laboratories, Inc.
    • 17.3.7. Clario
    • 17.3.8. EPS Corporation
    • 17.3.9. GVK Biosciences Private Limited
    • 17.3.10. ICON PLC
    • 17.3.11. Image Analysis Group
    • 17.3.12. Intelerad Medical Systems Incorporated
    • 17.3.13. IQVIA Inc.
    • 17.3.14. Median Technologies PLC
    • 17.3.15. Medidata by Dassault Systemes S.E.
    • 17.3.16. MERIT CRO, Inc.
    • 17.3.17. Micron, Inc.
    • 17.3.18. Mint Medical Inc.
    • 17.3.19. MUSASHI IMAGE JOHO CO.,LTD.
    • 17.3.20. Parexel International Corporation
    • 17.3.21. Perceptive Informatics LLC
    • 17.3.22. Visikol, Inc.
    • 17.3.23. WCG Clinical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IMAGING CRO MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IMAGING CRO MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IMAGING CRO MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMAGING CRO MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMAGING CRO MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMAGING CRO MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 20